Methylene blue protects against TDP-43 and FUS neuronal toxicity in C. elegans and D. rerio

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Vaccaro, Alexandra ^a,b,c   Patten, Shunmoogum A ^b,c   Ciura, Sorana ^b,c   Maios, Claudia ^b   Therrien, Martine ^a,b,c   Drapeau, Pierre ^b,c   Kabashi, Edor ^b,d   Parker, J Alex ^a,b,c  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FUSED IN SARCOMA PROTEIN; LITHIUM CHLORIDE; METHYLENE BLUE; MUTANT PROTEIN; RILUZOLE; TAR DNA BINDING PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DYSFUNCTION; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; DISEASE COURSE; EMBRYO; MOTOR NEURON DISEASE; NERVE CELL DEGENERATION; NERVE FIBER DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARALYSIS; PHENOTYPE; PROTEIN EXPRESSION; TRANSGENIC ANIMAL; ZEBRA FISH;

ANIMALS; BEHAVIOR, ANIMAL; CAENORHABDITIS ELEGANS; DNA-BINDING PROTEINS; HUMANS; METHYLENE BLUE; MOTOR NEURONS; MUTATION; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PHENOTYPE; RNA-BINDING PROTEIN FUS; TIME FACTORS; ZEBRAFISH;

ANIMALIA; CAENORHABDITIS ELEGANS; DANIO RERIO;

EID: 84864400774     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042117     Document Type: Article

References (35)

1. Boillee S, Vande Velde C, Cleveland DW, ((2006)) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52:: 39--59.
2. Lomen-Hoerth C, ((2008)) Amyotrophic lateral sclerosis from bench to bedside. Semin Neurol 28:: 205--211.
3. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, et al. ((2006)) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:: 130--133.
4. Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, et al. ((2008)) TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol.
5. Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, et al. ((2008)) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet.
6. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, et al. ((2008)) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319:: 1668--1672.
7. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, et al. ((2009)) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323:: 1205--1208.
8. Lagier-Tourenne C, Polymenidou M, Cleveland DW, ((2010)) TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 19:: R46--64.
9. Kabashi E, Bercier V, Lissouba A, Liao M, Brustein E, et al. ((2011)) FUS and TARDBP but not SOD1 interact in genetic models of Amyotrophic Lateral Sclerosis. PLoS Genet in press.
10. Wang JW, Brent JR, Tomlinson A, Shneider NA, McCabe BD, ((2011)) The ALS-associated proteins FUS and TDP-43 function together to affect Drosophila locomotion and life span. J Clin Invest.
11. Owens KN, Santos F, Roberts B, Linbo T, Coffin AB, et al. ((2008)) Identification of genetic and chemical modulators of zebrafish mechanosensory hair cell death. PLoS Genet 4:: e1000020.
12. Peterson RT, Link BA, Dowling JE, Schreiber SL, ((2000)) Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc Natl Acad Sci U S A 97:: 12965--12969.
13. Jones AK, Buckingham SD, Sattelle DB, ((2005)) Chemistry-to-gene screens in Caenorhabditis elegans. Nat Rev Drug Discov 4:: 321--330.
14. Kwok TC, Ricker N, Fraser R, Chan AW, Burns A, et al. ((2006)) A small-molecule screen in C. elegans yields a new calcium channel antagonist. Nature 441:: 91--95.
15. Vaccaro A, Tauffenberger A, Aggad D, Rouleau G, Drapeau P, et al. ((2012)) Mutant TDP-43 and FUS cause age-dependent paralysis and neurodegeneration in C. elegans. PLoS ONE 7:: e31321.
16. Kabashi E, Lin L, Tradewell ML, Dion PA, Bercier V, et al. ((2009)) Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum Mol Genet 19:: 671--683.
17. Kabashi E, Bercier V, Lissouba A, Liao M, Brustein E, et al. ((2011)) FUS and TARDBP but not SOD1 interact in genetic models of amyotrophic lateral sclerosis. PLoS Genet 7:: e1002214.
18. Schirmer RH, Adler H, Pickhardt M, Mandelkow E, ((2011)) "Lest we forget you- methylene blue..". Neurobiol Aging.
19. Cheah BC, Vucic S, Krishnan AV, Kiernan MC, ((2010)) Riluzole, neuroprotection and amyotrophic lateral sclerosis. Curr Med Chem 17:: 1942--1199.
20. Van Raamsdonk JM, Hekimi S, ((2009)) Deletion of the mitochondrial superoxide dismutase sod-2 extends lifespan in Caenorhabditis elegans. PLoS Genet 5:: e1000361.
21. Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, et al. ((2003)) An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell 11:: 619--633.
22. Necula M, Breydo L, Milton S, Kayed R, van der Veer WE, et al. ((2007)) Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization. Biochemistry 46:: 8850--8860.
23. Wischik CM, Edwards PC, Lai RY, Roth M, Harrington CR, ((1996)) Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. Proc Natl Acad Sci U S A 93:: 11213--11218.
24. Yamashita M, Nonaka T, Arai T, Kametani F, Buchman VL, et al. ((2009)) Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models. FEBS Lett 583:: 2419--2424.
25. Arai T, Hasegawa M, Nonoka T, Kametani F, Yamashita M, et al. ((2010)) Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy. Neuropathology 30:: 170--181.
26. Audet JN, Soucy G, Julien JP, ((2012)) Methylene blue administration fails to confer neuroprotection in two amyotrophic lateral sclerosis mouse models. Neuroscience.
27. Medina DX, Caccamo A, Oddo S, ((2011)) Methylene blue reduces abeta levels and rescues early cognitive deficit by increasing proteasome activity. Brain Pathol 21:: 140--149.
28. van Bebber F, Paquet D, Hruscha A, Schmid B, Haass C, ((2010)) Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish. Neurobiol Dis 39:: 265--271.
29. Simpson EP, Yen AA, Appel SH, ((2003)) Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis. Curr Opin Rheumatol 15:: 730--736.
30. Lin MT, Beal MF, ((2006)) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:: 787--795.
31. Naganska E, Matyja E, ((2011)) Amyotrophic lateral sclerosis- looking for pathogenesis and effective therapy. Folia Neuropathol 49:: 1--13.
32. Rojas JC, Bruchey AK, Gonzalez-Lima F, ((2012)) Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Prog Neurobiol 96:: 32--45.
33. Rojas JC, Simola N, Kermath BA, Kane JR, Schallert T, et al. ((2009)) Striatal neuroprotection with methylene blue. Neuroscience 163:: 877--889.
34. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF, ((1995)) Stages of embryonic development of the zebrafish. Dev Dyn 203:: 253--310.
35. Deng J, Yu L, Liu C, Yu K, Shi X, et al. ((2009)) Hexabromocyclododecane-induced developmental toxicity and apoptosis in zebrafish embryos. Aquat Toxicol 93:: 29--36.